financetom
Business
financetom
/
Business
/
Meta appoints Arun Srinivas as its India head
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Meta appoints Arun Srinivas as its India head
Jun 15, 2025 10:30 PM

June 16 (Reuters) - Meta Platforms ( META ) on Monday

said Arun Srinivas has been appointed as the managing director

and head for Meta in India.

(Reporting by Rishabh Jaiswal in Bengaluru)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
TriSalus Life Sciences, Geo-Med Partner to Expand TriNav Infusion System Access in VA Medical Centers
TriSalus Life Sciences, Geo-Med Partner to Expand TriNav Infusion System Access in VA Medical Centers
Nov 11, 2024
07:36 AM EST, 11/11/2024 (MT Newswires) -- TriSalus Life Sciences ( TLSI ) said Monday that it has partnered with Geo-Med, a certified service-disabled veteran-owned small business, to expand the availability of its TriNav Infusion System across US Department of Veterans Affairs medical centers. The company said Geo-Med is a key supplier to the Veterans Affairs and the US Department...
GoldMining Up 2.6% In US Premarket As Reports Additional High-Grade Drilling Results and Identified Multiple Drill Targets, Sao Jorge Project, Brazil
GoldMining Up 2.6% In US Premarket As Reports Additional High-Grade Drilling Results and Identified Multiple Drill Targets, Sao Jorge Project, Brazil
Nov 11, 2024
07:36 AM EST, 11/11/2024 (MT Newswires) -- GoldMining Inc. ( GLDG ) was at last look up 2.6% in US premarket trade -- it was even higher -- as the company reported Monday additional assay results from the 2024 auger drilling program at its 100% owned Sao Jorge Project in the Tapajos gold district, Para State, Brazil. Among highlights, it...
Can-Fite BioPharma Doses First Patient in Namodenoson Phase 2a Trial in Pancreatic Cancer
Can-Fite BioPharma Doses First Patient in Namodenoson Phase 2a Trial in Pancreatic Cancer
Nov 11, 2024
07:33 AM EST, 11/11/2024 (MT Newswires) -- Can-Fite BioPharma ( CANF ) said Monday that the first patient has been dosed in its phase 2a trial of Namodenoson in patients with advanced pancreatic adenocarcinoma. The company said it targets to enroll about 20 evaluable patients in the trial. The study's primary objective is to characterize Namodenoson's safety profile, while the...
Cigna says it will not pursue combination with Humana
Cigna says it will not pursue combination with Humana
Nov 11, 2024
Nov 11 (Reuters) - Health insurer Cigna Group ( CI ) said on Monday it is not pursuing a combination with peer Humana . ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved